Clinical Trials on Augmented Renal Clearance (ARC)
Total 30 results
-
Universitaire Ziekenhuizen KU LeuvenCompletedPrevalence of Augmented Renal Clearance | Risk Factors for Augmented Renal ClearanceBelgium
-
Forest LaboratoriesCompletedSystemic Inflammatory Response Syndrome (SIRS) | Augmented Renal Clearance (ARC)United States, Australia
-
Universitaire Ziekenhuizen KU LeuvenUniversity Hospital, Ghent; University Hospital, AntwerpUnknownCritical Illness | Augmented Renal ClearanceBelgium
-
Assistance Publique - Hôpitaux de ParisRecruitingCritically Ill | Augmented Renal ClearanceFrance
-
University of North Carolina, Chapel HillCompleted
-
University Hospital, GhentUniversity GhentCompletedAcute Kidney Injury | Pharmacokinetics | Renal Function | Augmented Renal Clearance | Iohexol | Critically Ill ChildrenBelgium
-
Shandong UniversityChildren's Hospital of Chongqing Medical UniversityRecruitingBacterial Meningitis | Augmented Renal ClearanceChina
-
McGill University Health Centre/Research Institute...Not yet recruitingCritical Illness | Traumatic Brain Injury | Polytrauma | Augmented Renal ClearanceCanada
-
National Taiwan University HospitalUnknownRenal Insufficiency, Chronic | Creatinine Clearance Quantitative Trait LocusTaiwan
-
Lumenis Be Ltd.UnknownStone ClearanceUnited States
-
Cairo UniversityUnknownInaccurate Transfer and Bond Failure of Conventional Indirect Bonding Tray | Accuracy of Bracket Transfer and Bond Failure Rate of Full Arch and Segmented Digitally Printed Trays
-
University Hospital, Strasbourg, FranceUnknownAcute Renal Failure (ARF)France
-
University Hospital of North NorwayRecruitingAcute Kidney Injury Due to Sepsis | Proximal Tubule Function | Lithium ClearanceNorway
-
University of ChicagoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsActive, not recruitingDialysis | End Stage Renal Disease (ESRD) | Brachiocephalic Fistula (BCF) | Cephalic Arch Stenosis (CAS)United States
-
IpsenCompletedAdvanced Renal Cell Carcinoma (aRCC)United Kingdom
-
Astellas Pharma IncCompletedPatients on Stable Chronic Maintenance Dialysis Who Are Receiving Hemodialysis Therapy | Pharmacodynamics of ASP7991 | Pharmacokinetics of ASP7991Japan
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingPrimary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1China
-
Bristol-Myers SquibbRecruitingAdvanced Renal Cell Carcinoma (aRCC)United States
-
Debiopharm International SARecruitingPancreatic Ductal Adenocarcinoma (PDAC) | Colorectal Cancer (CRC) | Clear Cell Renal Cell Cancer (ccRCC)France, Australia
-
Seoul National University HospitalUnknownCarcinoma, Renal Cell | Treatment Outcome | Pathology | Hemoglobin A1c Protein, HumanKorea, Republic of
-
Shanghai Zhongshan HospitalRecruitingTakayasu ArteritisChina
-
Calithera Biosciences, IncTerminatedClear Cell Renal Cell Carcinoma | Colorectal Cancer | Solid Tumor | CRC | TNBC - Triple-Negative Breast Cancer | ccRCC | RCCUnited States
-
National Cancer Institute (NCI)RecruitingKidney Cancer | Renal Cell Carcinoma | Urologic Malignant Disorders | Familial Renal Cancer (FRC) | Clear Cell Renal CancerUnited States
-
Kura Oncology, Inc.Mirati Therapeutics Inc.RecruitingNon Small Cell Lung Cancer (NSCLC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Colorectal Cancer (CRC) | Clear Cell Renal Cell Carcinoma (ccRCC) | Solid Tumors With HRAS AlterationsUnited States
-
Incyte CorporationCompletedHead and Neck Cancer | Gastric Cancer | Lung Cancer | Metastatic Cancer | Mesothelioma | Bladder Cancer | Solid Tumors | Renal Cell Carcinoma (RCC) | Colorectal Cancer (CRC) | UC (Urothelial Cancer)Italy, Spain, United States, Netherlands
-
Matthew EagletonMassachusetts General HospitalEnrolling by invitationAortic Dissection | Ascending Aortic Dissection | Thoracoabdominal Aortic Aneurysm | Thoracic Aortic Aneurysms | Dissecting, Aneurysm | Ascending Aorta Aneurysm | Aortic Arch; Aneurysm, Dissecting | Renal Artery Aneurysm | Superior Mesenteric Artery AneurysmUnited States
-
Incyte CorporationCompletedMelanoma | Breast Cancer | Head and Neck Cancer | Pancreatic Cancer | Lung Cancer | Endometrial Cancer | Solid Tumors | Renal Cell Carcinoma (RCC) | Colorectal Cancer (CRC) | UC (Urothelial Cancer) | MMR-deficient TumorsUnited States
-
Celldex TherapeuticsBristol-Myers SquibbCompletedSquamous Cell Carcinoma of the Head and Neck (SCCHN) | Ovarian Carcinoma-Enrollment Completed | Colorectal Cancer (CRC)-Enrollment Completed | Renal Cell Carcinoma (RCC) (Phase ll Only) | Glioblastoma (GBM) (Phase ll Only)-Enrollment CompletedUnited States
-
Incyte CorporationRecruitingMelanoma | Hepatocellular Carcinoma (HCC) | Renal Cell Carcinoma (RCC) | Colorectal Carcinoma (CRC) | Microsatellite Instability - High (MSI-H) | Mismatch Repair Deficient (dMMR)United States, Brazil, Canada, Australia, Slovakia, Sweden, Norway, Mexico
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedMelanoma | Lymphoma | Head and Neck Cancer | Gastric Cancer | Ovarian Cancer | Hepatocellular Carcinoma (HCC) | Lung Cancer | Bladder Cancer | Endometrial Cancer | Solid Tumors | Renal Cell Carcinoma (RCC) | Triple Negative Breast Cancer (TNBC) | UC (Urothelial Cancer) | Microsatellite-instability (MSI) High Colorectal...United States